Novo Holdings A/S 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-24 12:46 pm Sale |
2022-10-20 | 13D | Milestone Pharmaceuticals Inc. MIST |
Novo Holdings A/S | 1,378,538 4.600% |
-719,175 (-34.28%) |
Filing |
| 2022-09-26 4:04 pm Purchase |
2022-09-20 | 13D | Milestone Pharmaceuticals Inc. MIST |
Novo Holdings A/S | 2,097,713 7.000% |
16,828 (+0.81%) |
Filing |